Movement Alert|Thermo Fisher Scientific Intraday Rise 3.06% in Regular Trading, $5 Billion Buyback Authorization Supports Sentiment

Market Focus
12 hours ago

On November 10, Thermo Fisher Scientific rose 3.06% in Regular Trading, trading at $716.34 per share, with turnover of $638 million.

The move was accompanied by the company’s newly authorized share repurchase plan of up to $5 billion, which replaces the prior authorization that had about $1 billion remaining, while the quarterly dividend was maintained at $0.47 per share.

Background figures also show Thermo Fisher Scientific reported third-quarter adjusted EPS of $6.68 on revenue of $12.14 billion, both above market expectations. The combination of better-than-expected results and a larger buyback authorization reinforced investor confidence in cash generation and longer-term capital return.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10